Glad ya found it interesting. I did too (sorta), in my limited way, but then again, I boast no claim of being an ultra-sound geek, even though I might like to aspire to being one!! hee hee. I think maybe you have to be a super-sonic geek to really fathom the terminology, functions and appreciate the potential improvements here - but superficially ... it sounds good to me! I'd line up to volunteer for one. C.
Tig said
Nov 23, 2016
That's interesting! We pay $5-7K per probe for our standard Ultrasound machine. One of these would be very expensive. The image quality will no doubt be incredible. Nice to see the use of ultrasound in fibrosis diagnosis expanding.
Canuck said
Nov 22, 2016
FDA NEWS
FDA grants 510(k) clearance to new ultrasound modes for liver, breast imaging
November 22, 2016
SuperSonic Imagine announced the FDA granted 510(k) clearance to add additional imaging probes - for liver disease and breast lesions - for use with its Aixplorer platform.
Aixplorer (SuperSonic Imagine) is an ultrasound system that uses an UltraFast (SuperSonic Imagine) platform for the acquisition of images at a rate 200 times faster than other ultrasound systems. The clearance includes the following imaging modes to be used with the system: PlaneWave UltraSensitive Imaging (SuperSonic Imagine), TriVu, fusion and navigation, contrast liver imaging and B-mode Ratio, according to a press release.
"These new imaging modes provide unique information for the clinical management of patients with breast and liver disease,"Jacques Souquet, founder and chief innovation officer at SuperSonic Imagine, said in the release. "In particular, this new release will position SuperSonic Imagine as a leading innovator in the field of chronic liver diseases management and cover the whole spectrum of liver diseases from [nonalcoholic fatty liver disease] to [hepatocellular carcinoma]."
The Aixplorer system currently allows liver anatomy to be viewed in real time. This provides color and quantitative mapping of liver stiffness to make it easier to detect liver disease and fibrosis in a patient, according to a press release. The new probe provides an assessment of the liver echostructure, enabling the expansion of possibilities for patients with liver disease. Using Angio PL. U.S. and contrast mode, clinicians will be able to "visualize the vascularization and micro-vascularization" of liver lesions. The fusion and navigation will also enable ultrasound images to merge with other imaging techniques, such as magnetic resonance or computed tomography.
The breast package combines multiple probes, including a TriVu mode that combines anatomical, stiffness and Angio PL. U.S. microvascularization information. "This mode will offer a comprehensive visualization of breast lesions that had never been proposed in the field of ultrasound", according to SuperSonic.
Disclosure: Souquet is employed by SuperSonic Imagine.
Glad ya found it interesting. I did too (sorta), in my limited way, but then again, I boast no claim of being an ultra-sound geek, even though I might like to aspire to being one!! hee hee. I think maybe you have to be a super-sonic geek to really fathom the terminology, functions and appreciate the potential improvements here - but superficially ... it sounds good to me! I'd line up to volunteer for one.
C.
That's interesting! We pay $5-7K per probe for our standard Ultrasound machine. One of these would be very expensive. The image quality will no doubt be incredible. Nice to see the use of ultrasound in fibrosis diagnosis expanding.
FDA NEWS
FDA grants 510(k) clearance to new ultrasound modes for liver, breast imaging
November 22, 2016
SuperSonic Imagine announced the FDA granted 510(k) clearance to add additional imaging probes - for liver disease and breast lesions - for use with its Aixplorer platform.
Aixplorer (SuperSonic Imagine) is an ultrasound system that uses an UltraFast (SuperSonic Imagine) platform for the acquisition of images at a rate 200 times faster than other ultrasound systems. The clearance includes the following imaging modes to be used with the system: PlaneWave UltraSensitive Imaging (SuperSonic Imagine), TriVu, fusion and navigation, contrast liver imaging and B-mode Ratio, according to a press release.
"These new imaging modes provide unique information for the clinical management of patients with breast and liver disease," Jacques Souquet, founder and chief innovation officer at SuperSonic Imagine, said in the release. "In particular, this new release will position SuperSonic Imagine as a leading innovator in the field of chronic liver diseases management and cover the whole spectrum of liver diseases from [nonalcoholic fatty liver disease] to [hepatocellular carcinoma]."
The Aixplorer system currently allows liver anatomy to be viewed in real time. This provides color and quantitative mapping of liver stiffness to make it easier to detect liver disease and fibrosis in a patient, according to a press release. The new probe provides an assessment of the liver echostructure, enabling the expansion of possibilities for patients with liver disease. Using Angio PL. U.S. and contrast mode, clinicians will be able to "visualize the vascularization and micro-vascularization" of liver lesions. The fusion and navigation will also enable ultrasound images to merge with other imaging techniques, such as magnetic resonance or computed tomography.
The breast package combines multiple probes, including a TriVu mode that combines anatomical, stiffness and Angio PL. U.S. microvascularization information. "This mode will offer a comprehensive visualization of breast lesions that had never been proposed in the field of ultrasound", according to SuperSonic.
Disclosure: Souquet is employed by SuperSonic Imagine.